交易 GoodRx Holdings, Inc. - GDRX CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.06 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 5.49 | 0.34 | 6.60% | 5.15 | 5.54 | 5.15 |
May 25, 2023 | 5.20 | 0.16 | 3.17% | 5.04 | 5.23 | 4.96 |
May 24, 2023 | 5.11 | 0.05 | 0.99% | 5.06 | 5.19 | 5.03 |
May 23, 2023 | 5.18 | 0.04 | 0.78% | 5.14 | 5.30 | 5.10 |
May 22, 2023 | 5.24 | 0.24 | 4.80% | 5.00 | 5.28 | 4.98 |
May 19, 2023 | 5.04 | 0.00 | 0.00% | 5.04 | 5.14 | 5.01 |
May 18, 2023 | 5.11 | -0.01 | -0.20% | 5.12 | 5.27 | 5.02 |
May 17, 2023 | 5.22 | 0.18 | 3.57% | 5.04 | 5.26 | 4.94 |
May 16, 2023 | 5.04 | -0.02 | -0.40% | 5.06 | 5.25 | 4.98 |
May 15, 2023 | 5.19 | 0.20 | 4.01% | 4.99 | 5.24 | 4.93 |
May 12, 2023 | 5.07 | 0.14 | 2.84% | 4.93 | 5.12 | 4.89 |
May 11, 2023 | 4.97 | 0.28 | 5.97% | 4.69 | 5.00 | 4.55 |
May 10, 2023 | 4.77 | 0.39 | 8.90% | 4.38 | 4.95 | 4.14 |
May 9, 2023 | 4.67 | 0.14 | 3.09% | 4.53 | 4.70 | 4.51 |
May 8, 2023 | 4.58 | 0.09 | 2.00% | 4.49 | 4.65 | 4.46 |
May 5, 2023 | 4.58 | 0.16 | 3.62% | 4.42 | 4.64 | 4.28 |
May 4, 2023 | 4.36 | 0.06 | 1.40% | 4.30 | 4.37 | 4.22 |
May 3, 2023 | 4.33 | -0.09 | -2.04% | 4.42 | 4.49 | 4.29 |
May 2, 2023 | 4.42 | -0.04 | -0.90% | 4.46 | 4.55 | 4.40 |
May 1, 2023 | 4.56 | 0.03 | 0.66% | 4.53 | 4.66 | 4.53 |
GoodRx Holdings, Inc. Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Thursday, June 8, 2023 | ||
时间(协调世界时) (UTC) 19:30 | 国家/地区 US
| 事件 GoodRx Holdings Inc at Jefferies Healthcare Conference GoodRx Holdings Inc at Jefferies Healthcare ConferenceForecast -Previous - |
Wednesday, June 14, 2023 | ||
时间(协调世界时) (UTC) 18:00 | 国家/地区 US
| 事件 Goodrx Holdings Inc Annual Shareholders Meeting Goodrx Holdings Inc Annual Shareholders MeetingForecast -Previous - |
时间(协调世界时) (UTC) 18:00 | 国家/地区 US
| 事件 GoodRx Holdings Inc Annual Shareholders Meeting GoodRx Holdings Inc Annual Shareholders MeetingForecast -Previous - |
Monday, August 7, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家/地区 US
| 事件 Q2 2023 Goodrx Holdings Inc Earnings Release Q2 2023 Goodrx Holdings Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家/地区 US
| 事件 Q3 2023 Goodrx Holdings Inc Earnings Release Q3 2023 Goodrx Holdings Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 766.554 | 745.424 | 550.7 | 388.224 | 249.522 |
收入 | 766.554 | 745.424 | 550.7 | 388.224 | 249.522 |
收入成本,共计 | 65.079 | 46.716 | 29.587 | 14.016 | 6.035 |
毛利 | 701.475 | 698.708 | 521.113 | 374.208 | 243.487 |
总营业费用 | 764.816 | 732.018 | 826.419 | 253.425 | 175.128 |
销售/一般/行政费用,总计 | 487.341 | 524.903 | 715.586 | 191.659 | 112.536 |
研究与开发 | 143.137 | 125.86 | 61.816 | 29.3 | 43.894 |
Depreciation / Amortization | 54.177 | 34.539 | 18.43 | 13.573 | 9.806 |
营业收入 | 1.738 | 13.406 | -275.719 | 134.799 | 74.394 |
利息收入(费用),非经营净值 | -24.969 | -23.583 | -27.753 | -48.854 | -22.039 |
其他,净值 | 0 | 0 | 0.022 | -2.967 | -0.007 |
税前净收入 | -23.231 | -10.177 | -303.45 | 82.978 | 52.348 |
税后净收入 | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
未计算非常项目前的净收益 | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
净收入 | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
普通股股东可获收益 (不含非经常性项目) | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
普通股股东可获收益 (含非經常性項目) | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
摊薄净收入 | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
摊薄后加权平均股 | 412.858 | 409.981 | 274.696 | 383.223 | 383.223 |
扣除特别项目的每股摊薄盈利 | -0.07951 | -0.0616 | -1.0689 | 0.17235 | 0.11428 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
每股正常摊薄盈利 | -0.04353 | -0.03893 | -1.06654 | 0.18248 | 0.12051 |
异常费用(收入) | 15.082 | 0 | 1 | 4.877 | 2.857 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 183.986 | 184.109 | 187.318 | 191.798 | 203.329 |
收入 | 183.986 | 184.109 | 187.318 | 191.798 | 203.329 |
收入成本,共计 | 16.695 | 17.36 | 17.395 | 18.044 | 12.28 |
毛利 | 167.291 | 166.749 | 169.923 | 173.754 | 191.049 |
总营业费用 | 174.491 | 182.372 | 203.031 | 195.845 | 183.568 |
销售/一般/行政费用,总计 | 108.141 | 121.257 | 117.107 | 126.077 | 122.9 |
研究与开发 | 32.908 | 36.77 | 35.921 | 35.404 | 35.042 |
Depreciation / Amortization | 14.939 | 15.533 | 13.952 | 13.319 | 11.373 |
营业收入 | 9.495 | 1.737 | -15.713 | -4.047 | 19.761 |
利息收入(费用),非经营净值 | -5.899 | -6.482 | -6.558 | -6.112 | -5.817 |
税前净收入 | 3.596 | -4.745 | -22.271 | -10.159 | 13.944 |
税后净收入 | -3.29 | -1.972 | -41.734 | -1.415 | 12.293 |
未计算非常项目前的净收益 | -3.29 | -1.972 | -41.734 | -1.415 | 12.293 |
净收入 | -3.29 | -1.972 | -41.734 | -1.415 | 12.293 |
普通股股东可获收益 (不含非经常性项目) | -3.29 | -1.972 | -41.734 | -1.415 | 12.293 |
普通股股东可获收益 (含非經常性項目) | -3.29 | -1.972 | -41.734 | -1.415 | 12.293 |
摊薄净收入 | -3.29 | -1.972 | -41.734 | -1.415 | 12.293 |
摊薄后加权平均股 | 412.429 | 411.67 | 412.956 | 412.135 | 427.378 |
扣除特别项目的每股摊薄盈利 | -0.00798 | -0.00479 | -0.10106 | -0.00343 | 0.02876 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.00346 | -0.02028 | -0.06244 | 0.00579 | 0.03348 |
其他,净值 | |||||
异常费用(收入) | 1.808 | -8.548 | 18.656 | 3.001 | 1.973 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 919.686 | 1088.83 | 1086.37 | 86.582 | 73.071 |
现金和短期投资 | 757.165 | 941.109 | 968.691 | 26.05 | 34.6 |
Cash | 757.165 | 941.109 | 968.691 | 26.05 | 34.6 |
应收账款总额,净额 | 121.665 | 126.411 | 97.293 | 48.129 | 35.023 |
Accounts Receivable - Trade, Net | 117.141 | 118.08 | 68.729 | 48.129 | 33.359 |
Prepaid Expenses | 40.856 | 21.307 | 17.484 | 12.403 | 3.448 |
Total Assets | 1604.63 | 1607.62 | 1470.11 | 386.796 | 314.791 |
Property/Plant/Equipment, Total - Net | 55.726 | 49.317 | 50.769 | 34.175 | 0.988 |
Property/Plant/Equipment, Total - Gross | 65.495 | 55.146 | 52.899 | 35.442 | 1.542 |
Accumulated Depreciation, Total | -9.769 | -5.829 | -2.13 | -1.267 | -0.554 |
Goodwill, Net | 412.117 | 329.696 | 261.116 | 236.225 | 220.42 |
Intangibles, Net | 189.937 | 133.778 | 56.719 | 26.445 | 18.27 |
Other Long Term Assets, Total | 27.165 | 6.007 | 15.142 | 3.369 | 2.042 |
Total Current Liabilities | 76.32 | 81.113 | 59.551 | 33.373 | 16.62 |
Accounts Payable | 17.7 | 17.501 | 10.291 | 7.851 | 7.2 |
Accrued Expenses | 43.712 | 49.714 | 35.379 | 13.691 | 3.732 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.029 | 7.029 | 7.029 | 7.029 | 5.43 |
Other Current Liabilities, Total | 7.879 | 6.869 | 6.852 | 4.802 | 0.258 |
Total Liabilities | 789.804 | 775.945 | 758.755 | 737.369 | 740.209 |
Total Long Term Debt | 651.796 | 655.858 | 659.888 | 663.893 | 716.806 |
Long Term Debt | 651.796 | 655.858 | 659.888 | 663.893 | 716.806 |
Deferred Income Tax | 0.244 | 3.456 | |||
Other Liabilities, Total | 61.688 | 38.73 | 39.316 | 40.103 | 3.327 |
Total Equity | 814.827 | 831.68 | 711.359 | -350.573 | -425.418 |
Redeemable Preferred Stock | 0 | 0 | 737.009 | 737.009 | |
Common Stock | 0.04 | 0.04 | 0.039 | 0.46 | 0.451 |
Retained Earnings (Accumulated Deficit) | -1448.54 | -1415.71 | -1390.45 | -1096.83 | -1162.88 |
Total Liabilities & Shareholders’ Equity | 1604.63 | 1607.62 | 1470.11 | 386.796 | 314.791 |
Total Common Shares Outstanding | 397.025 | 398.681 | 391.66 | 383.223 | 383.223 |
Additional Paid-In Capital | 2263.32 | 2247.35 | 2101.77 | 8.788 | |
Other Current Assets, Total | 0 | 2.9 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 907.016 | 919.686 | 878.388 | 893.957 | 994.723 |
现金和短期投资 | 761.075 | 757.165 | 728.786 | 730.54 | 845.427 |
Cash | 761.075 | 757.165 | 728.786 | 730.54 | 845.427 |
应收账款总额,净额 | 116.442 | 121.665 | 124.25 | 143.194 | 129.107 |
Accounts Receivable - Trade, Net | 116.442 | 117.141 | 120.886 | 122.878 | 123.281 |
Prepaid Expenses | 29.499 | 40.856 | 25.352 | 20.223 | 20.189 |
Other Current Assets, Total | |||||
Total Assets | 1611.5 | 1604.63 | 1567.06 | 1592 | 1538.33 |
Property/Plant/Equipment, Total - Net | 53.683 | 55.726 | 50.258 | 51.384 | 49.542 |
Goodwill, Net | 412.117 | 412.117 | 415.256 | 415.256 | 334.642 |
Intangibles, Net | 197.303 | 189.937 | 197.199 | 193.419 | 138.495 |
Other Long Term Assets, Total | 41.381 | 27.165 | 25.958 | 37.98 | 20.926 |
Total Current Liabilities | 68.981 | 76.32 | 84.966 | 79.618 | 59.364 |
Accounts Payable | 12.389 | 17.7 | 10.855 | 16.825 | 12.82 |
Accrued Expenses | 35.062 | 43.712 | 56.084 | 44.221 | 29.196 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.029 | 7.029 | 7.029 | 7.029 | 7.029 |
Other Current Liabilities, Total | 14.501 | 7.879 | 10.998 | 11.543 | 10.319 |
Total Liabilities | 784.032 | 789.804 | 778.656 | 774.056 | 751.821 |
Total Long Term Debt | 650.776 | 651.796 | 652.814 | 653.83 | 654.845 |
Long Term Debt | 650.776 | 651.796 | 652.814 | 653.83 | 654.845 |
Other Liabilities, Total | 64.275 | 61.688 | 40.226 | 40.153 | 37.215 |
Total Equity | 827.468 | 814.827 | 788.403 | 817.94 | 786.507 |
Common Stock | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Additional Paid-In Capital | 2279.25 | 2263.32 | 2234.93 | 2222.73 | 2189.88 |
Retained Earnings (Accumulated Deficit) | -1451.82 | -1448.54 | -1446.56 | -1404.83 | -1403.41 |
Total Liabilities & Shareholders’ Equity | 1611.5 | 1604.63 | 1567.06 | 1592 | 1538.33 |
Total Common Shares Outstanding | 396.649 | 397.025 | 396.065 | 397.908 | 396.132 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Deferred Income Tax | 0.65 | 0.455 | 0.397 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
经营活动产生的现金 | 146.78 | 178.779 | 131.341 | 83.286 | 45.253 |
经营活动产生的现金 | 54.177 | 34.539 | 18.43 | 13.573 | 9.806 |
Deferred Taxes | -0.497 | 12.851 | -10.91 | -5.674 | -2.433 |
非现金物品 | 146.218 | 168.439 | 449.903 | 14.155 | 5.858 |
Cash Taxes Paid | -4.356 | 18.105 | 29.228 | 19.4 | 11.7 |
已付现金利息 | 30.702 | 20.198 | 24.517 | 48.443 | 18.658 |
营运资金的变化 | -20.29 | -11.796 | -32.459 | -4.816 | -11.771 |
投资活动产生的现金 | -210.498 | -178.733 | -91.617 | -37.055 | -3.458 |
资本支出 | -55.214 | -34.457 | -35.824 | -5.749 | -3.458 |
其他投资现金流量项目,总计 | -155.284 | -144.276 | -55.793 | -31.306 | 0 |
融资活动产生的现金 | -120.226 | -30.528 | 905.817 | -54.781 | -24.734 |
融资现金流项目 | -20.635 | -58.52 | 15.043 | -2.214 | -1371.97 |
股票的发行(报废),净额 | -92.562 | 35.021 | 897.803 | 4.665 | 740.358 |
债务的发行(退还),净额 | -7.029 | -7.029 | -7.029 | -57.232 | 606.876 |
现金净变化 | -183.944 | -30.482 | 945.541 | -8.55 | 17.061 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.29 | -32.828 | -30.856 | 10.878 | 12.293 |
Cash From Operating Activities | 32.288 | 146.78 | 114.901 | 81.169 | 30.12 |
Cash From Operating Activities | 14.939 | 54.177 | 38.644 | 24.692 | 11.373 |
Deferred Taxes | 0.035 | -0.497 | -0.141 | -0.336 | -0.394 |
Non-Cash Items | 29.198 | 146.218 | 112.553 | 65.241 | 31.732 |
Changes in Working Capital | -8.594 | -20.29 | -5.299 | -19.306 | -24.884 |
Cash From Investing Activities | -14.288 | -210.498 | -211.784 | -198.009 | -34.401 |
Capital Expenditures | -14.288 | -55.214 | -39.924 | -26.149 | -12.418 |
Cash From Financing Activities | -14.09 | -120.226 | -115.44 | -93.729 | -91.401 |
Financing Cash Flow Items | -3.523 | -20.635 | -17.557 | -14.288 | -9.561 |
Issuance (Retirement) of Stock, Net | -8.809 | -92.562 | -92.611 | -75.926 | -80.082 |
Issuance (Retirement) of Debt, Net | -1.758 | -7.029 | -5.272 | -3.515 | -1.758 |
Net Change in Cash | 3.91 | -183.944 | -212.323 | -210.569 | -95.682 |
Other Investing Cash Flow Items, Total | 0 | -155.284 | -171.86 | -171.86 | -21.983 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 10.0567 | 8360759 | 42454 | 2023-03-31 | LOW |
Silver Lake Partners | Private Equity | 4.2488 | 3532276 | 0 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 3.454 | 2871518 | 60381 | 2023-03-31 | HIGH |
Millennium Management LLC | Hedge Fund | 3.3479 | 2783370 | -2535233 | 2023-03-31 | HIGH |
Perot Investments | Investment Advisor/Hedge Fund | 3.073 | 2554812 | 112308 | 2023-03-31 | |
Renaissance Technologies LLC | Hedge Fund | 2.7032 | 2247322 | 340100 | 2023-03-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.0474 | 1702114 | -138880 | 2023-03-31 | LOW |
OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 2.0448 | 1700000 | 1312433 | 2023-03-31 | LOW |
Technology Crossover Ventures | Venture Capital | 1.989 | 1653566 | 0 | 2023-03-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.7958 | 1492983 | -1779425 | 2023-03-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 1.7048 | 1417330 | 236050 | 2023-03-31 | MED |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.601 | 1331000 | 456576 | 2023-03-31 | LOW |
Assenagon Asset Management S.A. | Investment Advisor | 1.3593 | 1130051 | 1130051 | 2023-03-31 | HIGH |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 1.3571 | 1128257 | -96590 | 2023-03-31 | MED |
ExodusPoint Capital Management, LP | Hedge Fund | 1.222 | 1015908 | 642563 | 2023-03-31 | HIGH |
Goldman Sachs & Company, Inc. | Research Firm | 1.0203 | 848242 | 439239 | 2023-03-31 | MED |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.9975 | 829292 | 735011 | 2023-03-31 | LOW |
Bezdek (Trevor) | Individual Investor | 0.9752 | 810707 | 0 | 2023-04-17 | LOW |
Hirsch (Douglas Joseph) | Individual Investor | 0.9752 | 810707 | 0 | 2023-04-17 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.951 | 790604 | 51326 | 2023-03-31 | LOW |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
GoodRx Holdings, Inc. Company profile
关于 Goodrx Holdings Inc
GoodRx Holdings, Inc.是一家以消费者为中心的数字医疗平台。 公司提供GoodRx平台,该平台汇总和分析来自一系列不同来源的价格数据。 该平台通过其远程医疗产品GoodRx Care和GoodRx Telehealth Marketplace以及其他医疗保健相关内容,提供药物储蓄计划、医疗机构咨询和实验室测试。 它的处方产品提供处方的价格比较和谈判价格。 它的订阅产品为消费者及其家庭提供了在选定的药店以较低的处方价格购买选定的药物的机会,并收取每月或每年的订阅费。 它的医药制造商提供负担得起的解决方案,如共付卡、病人援助计划、护理门户网站和其他节约方案。 它的处方交易服务提供了精心策划的、与地域相关的价格比较和处方的谈判价格。
Industry: | Online Services (NEC) |
2701 Olympic Boulevard
Suite 990
SANTA MONICA
CALIFORNIA 90404
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球530,000万多名交易者的一份子,选择利用Capital.com进行交易吧。